Anchiano Therapeutics Ltd ADR (ANCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANCN | ABVC | ALGS | ||
| Company | Anchiano Therapeutics Ltd ADR | Abvc Biopharma Inc | Aligos Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.10 | 1.3800 | 5.25 | ||
| High | 8.20 | 1.4100 | 5.44 | ||
| Low | 4.60 | 1.3020 | 5.16 | ||
| Latest | 4.71 | 1.3500 | 5.28 | ||
| Change | +0.24 | -0.0100 | -0.07 | ||
| % Change | +5.37% | -0.74% | -1.31% | ||
| Volume | 25,037,500 | 77,000 | 39,800 | ||
| 20-Day Average Volume | 4,785,015 | 143,795 | 102,275 | ||
| Previous Close | 4.47 | 1.3600 | 5.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.07 | 1.3060 | 5.34 | ||
| 20-Day Raw Stochastic | 37.68% | 71.04% | 36.64% | ||
| 20-Day Relative Strength | 56.58 | 54.87 | 43.77 | ||
| Weighted Alpha | +284.79 | -54.09 | -56.30 | ||
| Today's Opinion | 96% Buy | 24% Sell | 100% Sell | ||
| Previous Opinion | 96% Buy | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.92% since 03/09/21 | +3.05% since 06/11/26 | unch since 06/11/26 | ||
| Low | 4.03 on 03/10/21 | 1.1900 on 06/15/26 | 4.98 on 06/16/26 | ||
| High | 8.20 on 03/16/21 | 1.4327 on 06/17/26 | 5.73 on 06/17/26 | ||
| 1-Month | |||||
| %Chg | -3.68% since 02/16/21 | +26.17% since 05/18/26 | -1.49% since 05/18/26 | ||
| Low | 2.60 on 03/04/21 | 1.0150 on 05/19/26 | 4.80 on 06/05/26 | ||
| High | 8.20 on 03/16/21 | 1.4845 on 06/05/26 | 6.11 on 05/22/26 | ||
| 3-Month | |||||
| %Chg | +79.77% since 12/16/20 | +10.66% since 03/18/26 | -24.03% since 03/18/26 | ||
| Low | 1.65 on 01/04/21 | 0.8801 on 03/30/26 | 4.80 on 06/05/26 | ||
| High | 10.55 on 02/10/21 | 1.7500 on 04/07/26 | 8.97 on 04/14/26 | ||
| 6-Month | |||||
| %Chg | +344.34% since 09/16/20 | -33.82% since 12/18/25 | -49.08% since 12/18/25 | ||
| Low | 0.91 on 10/22/20 | 0.8801 on 03/30/26 | 4.80 on 06/05/26 | ||
| High | 10.55 on 02/10/21 | 2.5300 on 12/26/25 | 11.50 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,948 | 35,100 | 32,672 | ||
| Shares Outstanding, K | 7,420 | 26,000 | 6,188 | ||
| Annual Sales | 0 | 0 | 2,190,000 | ||
| Annual Net Income | -11,610,000 | -7,910,000 | -24,190,000 | ||
| Last Quarter Sales | 0 | 0 | 2,830,000 | ||
| Last Quarter Net Income | -2,140,000 | -3,560,000 | -23,040,000 | ||
| 60-Month Beta | 0.95 | 0.56 | 2.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.06 on 05/18/26 | -2.21 on 05/07/26 | ||
| Earnings Date | 05/06/21 | 08/12/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||